For the study, researchers examined data on 2,613 patients who underwent joint replacement procedures with metal-containing implants and were subsequently evaluated for unexplained postoperative joint pain. Approximately 60 percent of the patients were women.
Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!
On a 10-point scale, women had an average pain score of 6.8, as compared to the average pain score for men, which was 6.1. The patients all underwent a blood test to evaluate sensitization to metals.
Around 49 percent of women tested positive for metal sensitization, as compared to 38 percent of men. Additionally, women tended to have a higher severity of metal sensitivity among those patients who tested positive.
“This supports both our hypothesis and previous reports that females may have a higher risk of adverse responses to implant metals,” study authors wrote.
More articles on healthcare quality:
Building your contingency resources: designing an enterprise resource pool
Bon Secours St. Mary’s undergoes deep clean after 6 bacterial infections
Dr. Peter Pronovost: This unnecessary regulation doesn’t benefit patients and costs $500M each year
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
